Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Karen Smith
Age : 52
Public asset : 1,724,641 USD
Country of residence : Unknown
Linked companies : Acceleron Pharma Inc. - Emergent BioSolutions Inc. - Sangamo Therapeutics, Inc. - Antares Pharma, Inc.

Biography of Karen Smith 
Dr. Karen L. Smith is a Chief Medical Officer at Emergent BioSolutions, Inc., an Independent Director at Antares Pharma, Inc., an Independent Director at Sangamo Therapeutics, Inc. and an Independent Director at Acceleron Pharma, Inc. She is on the Board of Directors at Antares Pharma, Inc., Sangamo Therapeutics, Inc. and Acceleron Pharma, Inc. Dr. Smith was previously employed as a President & Chief Executive Officer by Medeor Therapeutics, Inc., a Chief Executive Officer by Eliminate Cancer, Inc., a Director & Vice President by Celator Pharmaceuticals, Inc., a Non-Executive Director by Forward Pharma A/S, a Chief Medical Officer & EVP-Research & Development by Jazz Pharmaceuticals Plc, a SVP-Global Medical Affairs & Head-Dermatology by Allergan, Inc., a Head-External Medical Relations by AstraZeneca LP, a Head-US Clinical Operations by Bristol Myers Squibb Co., and a Chief Executive Officer by Boron Molecular Ltd. She also served on the board at Sucampo Pharmaceuticals, Inc. She received her undergraduate degree from Curtin University of Technology, a graduate degree from the University of Salford, an MBA from the University of New England (Australia), a doctorate degree from the University of Warwick and a doctorate degree from The University of Western Australia.


Current positions of Karen Smith 
Holdings of Karen Smith 
Karen Smith : Personal Network 
Most Read News 
10/15JACK DORSEY : Square CEO Dorsey says looking to build a bitcoin mining system - tweet
RE
10/20JACK MA : Alibaba founder Ma spotted in Mallorca in rare trip abroad after China scrutiny
RE
10/17ELON MUSK : Tesla's Musk dials into Volkswagen executive conference
RE
10/22WARREN BUFFETT : Generali closer to controlling Cattolica after Buffett tenders shares - source
RE
10/21ALEXANDRE RICARD : Pernod Ricard 1Q Sales Soar as Drinkers Head to the Bars
DJ
10/13WARREN BUFFETT : Buffett-backed Nubank turns a profit in Brazil
RE
10/25ELON MUSK : WRAPUP 3-Tesla zooms past $1 trillion market cap on bet that the EV future is now
RE
10/18BILL GATES : Electric vehicle battery startup ONE backed by BMW, Gates-led firm
RE
10/20ELON MUSK : No Elon Musk Show during this Tesla quarterly call
RE
10/18MATTHEW MOULDING : THG's Moulding gives up 'golden share' after stock tumbles
RE
More news


© 2021 People and Ownership :   
Karen Smith : Connections 


Latest news about Karen Smith 
10/06Science 37, Inc. completed the acquisition of LifeSci Acquisition II Corp. from LifeSci Holdings, LLC and others in a reverse merger transaction.
CI
07/28Reservoir Media Management, Inc. completed the acquisition of Roth CH Acquisition II Co. from CR Financial Holdings, Inc., Polar Asset Management Partners Inc., Castle Creek Arbitrage, LLC, 683 Capital Management, LLC and others in a reverse merger transaction.
CI
07/23Microvast, Inc. completed the acquisition of Tuscan Holdings Corp. from Polar Asset Management Partners Inc., Weiss Asset Management LP, Stephen A. Vogel and others in a reverse merger transaction.
CI
05/24NeuroRx, Inc. completed the acquisition of Big Rock Partners Acquisition Corp. from BRAC Lending Group LLC, EarlyBirdCapital, Inc., Big Rock and others in a reverse merger transaction.
CI
05/07Science 37, Inc. entered into a definitive agreement to acquire LifeSci Acquisition II Corp. from LifeSci Holdings, LLC and others in a reverse merger transaction for $1.1 billion.
CI
04/20Kontoor Brands Appoints Karen Smith as Executive Vice President of Global Supply Chain
CI
04/16MyMD Pharmaceuticals, Inc. completed the acquisition of Akers Biosciences, Inc. in a reverse merger transaction.
CI
More news